Nasdaq · Ophthalmic Goods
77 entities across 27 jurisdictions. Read directly from the company’s own 10-K EX-21 filed 2025-12-05 — see the exhibit.
Which other public companies file entities in the same places:
| Entity | Jurisdiction | Note |
|---|---|---|
| The Cooper Companies, Inc. | Delaware | |
| CooperVision, Inc. | New York | |
| Eyecare Prime LLC | California | |
| Paragon Vision Sciences, Inc. | Arizona | |
| SynergEyes, Inc. | California | |
| SynergEyes UK Ltd. | United Kingdom | |
| Cooper Global Holdings, Inc. | Delaware | |
| TCC Holdings LLC | Delaware | |
| CooperVision Global Ltd. | United Kingdom | |
| CooperVision do Brasil Ltda | Brazil | |
| CooperVision Singapore Pte Ltd |
Two standard screens, computed from the XBRL in FY2025 against FY2024. Every test shows the numbers behind it — a score with its inputs hidden is a number you cannot check.
Bankruptcy-risk screen combining working capital, retained earnings, operating income, market value against liabilities, and asset turnover. Above 2.99 is the safe zone; below 1.81 is distress.
| Year | Revenue | Net income | Free cash flow | Gross margin | Shares |
|---|---|---|---|---|---|
| FY2020 | $2.4B | $238.4M | $176.2M | 63.1% | 49,600,000 |
| FY2021 | $2.9B | $2.9B | $524.2M | 66.9% | 49,800,000 |
| FY2022 | $3.3B | $385.8M | $450.4M | 64.7% | 49,700,000 |
| FY2023 | $3.6B | $294.2M | $215.0M | 65.6% | 49,800,000 |
| FY2024 | $3.9B | $392.3M | $288.1M | 66.6% | 200,400,000 |
What the company actually paid out and bought back, as reported — the record behind any yield figure.
Ownership percentages are a vendor aggregate, not a filing — unlike everything else on this page.
COOPER COMPANIES, INC. files under SIC 3851 — all 3 ophthalmic goods companies compared on assets and F-score.
The structure map above is the Corporate Blueprint, and in the desktop it is interactive — click any entity to re-centre the map on it and walk the ownership chain. It sits alongside the screener, the scorecard and the filings lab on one desk, on your machine.
Sourced from SEC EDGAR primary filings. Figures are as reported by the company and are not investment advice. Scores are standard published screens computed from those filings; every input is shown above so you can check the arithmetic.
| Singapore |
| CooperVision Optical Trade (Shanghai) Ltd | China |
| CVI Contact Lens Pvt. Ltd. | India |
| CooperVision International Ltd. | United Kingdom |
| CooperVision Manufacturing Puerto Rico LLC | Puerto Rico |
| CooperVision (UK) Holdings Ltd. | United Kingdom |
| CooperVision Ltd. | United Kingdom |
| CooperVision Manufacturing Limited | United Kingdom |
| CooperVision Australia Pty Limited | Australia |
| CooperVision Distribution Srl | Belgium |
| CooperVision Canada Corp. | Canada |
| CooperVision S.A.S. | France |
| CooperVision GmbH | Germany |
| CooperVision Italia s.r.l. | Italy |
| CooperVision Nederland BV | Netherlands |
| CooperVision Nederland, Belgian Branch | Belgium |
| CooperVision Japan, Inc. | Japan |
| CooperVision Iberia SL | Spain |
| CooperVision S.A. (Pty) Limited | South Africa |
| CooperVision Nordic AB | Sweden |
| CooperVision Sarl | Switzerland |
| CooperVision RUS LLC | Russia |
| CooperVision Israel Ltd. | Israel |
| CooperVision Lens Care Ltd. | United Kingdom |
| Sauflon CL Ltd. | United Kingdom |
| CooperVision CL Kft | Hungary |
| Cooper Medical, Inc. | Delaware |
| CooperSurgical, Inc. | Delaware |
| CooperGenomics, Inc. | Delaware |
| Invitro Genetics LLC | Delaware |
| Reprogenetics LLC | Delaware |
| LifeGlobal Group LLC | Connecticut |
| Generate Parent LLC | Delaware |
| Cooper Surgical Holdings Ltd. | United Kingdom |
| Insception Biosciences Inc. | Canada |
| Invitro Genetics Ltd. | United Kingdom |
| Research Instruments Ltd. | United Kingdom |
| Origio A/S | Denmark |
| Generate Intermediate LLC | Delaware |
| Generate Life Sciences LLC | Delaware |
| Generate GCP Coinvest LLC | Delaware |
| Generate L Blocker LLC | Delaware |
| Generate NQ Blocker LLC | Delaware |
| Generate LNQ Holdings LLC | Delaware |
| Cryobank Holdings LLC | Delaware |
| California Cryobank LLC | Delaware |
| CCB-Kitazato LLC | Delaware |
| CCB-DEB LLC | Delaware |
| CCB-Fertility Tech LLC | Delaware |
| Donor Application LLC | Delaware |
| DEB Donor Egg Bank Canada Ltd | Canada |
| California Cryobank Stem Cell Services LLC | Delaware |
| CCB-NWC LLC | Delaware |
| CCB-MCB LLC | Delaware |
| Generate IP Holdings LLC | Delaware |
| Generate Sperm Bank Canada Ltd. | Canada |
| CBR Acquisition Holdings Corp. | Delaware |
| CBR Systems, Inc. | Delaware |
| Generate International LLC | Delaware |
| Generate Life Sciences Australia Pty Ltd | Australia |
| Generate CC Australia Pty Ltd | Australia |
| SC Storage Holdings Pty Ltd | Australia |
| SC Storage Finance Pty Ltd | Australia |
| SC Storage Operations Pty Ltd | Australia |
| Cell Care Australia Pty Ltd | Australia |
| Cell Care Australia Pty Ltd, New Zealand Branch | Australia |
| CooperSurgical Distribution B.V. | Netherlands |
| FY2025 |
| $4.1B |
| $374.9M |
| $433.7M |
| 65.5% |
| 200,000,000 |